HUAPONT PHARM.

INFORMATION CENTER

13

2021

-

04

华邦医药产业基地项目配套环境保护设施竣工及调试运行公示

Author:


华邦医药产业基地项目配套环境保护设施
竣工及调试运行公示
华邦医药产业基地项目位于两江新区水土高新园A02-1/01号地块。
项目名称:华邦医药产业基地项目
建设单位:重庆华邦制药有限公司
建设地点:两江新区水土高新园A02-1/01号地块
建设性质:新建
占地面积:113516.36m2(约170.2737亩)
劳动定员:总定员400人左右
生产制度:实行一班工作制,年工作300天。
总投资:103800万元
项目进度:计划2016年11月开工建设,2018年11月建成投产。
建设规模:华邦医药产业基地项目总的生产规模为:年产片剂20亿片、硬胶囊剂6亿粒、软胶囊剂2500万粒、颗粒剂1500万袋、口服液体制剂 1亿支、注射剂6000万支、外用制剂1.7亿支。工程建筑物包含A1、A2、C1制剂楼,B1质检大楼,B2物流中心及D1、D2、D3、D4、D5、D6、F1、F2等公用配套建筑。
建设项目及其配套建设的环境保护设施已建设完成并于2020年12月13日竣工完成。
根据调试预运行计划,拟对配套环境保护设施进行调试,调试运行起止时间:2020年1月5日-2020年3月5日。
重庆华邦制药有限公司
2021年2月26日

调试,建设,项目,医药,配套,产业基地,2020年,运行,设施

Latest News

2022-09-20

A new base of Huapont was officially completed and put into use

On September 19, 2022, the completion and commissioning ceremony of a new base was held, the new base is located in Changshou District, Chongqing. The construction of Changshou Base started on October 8, 2019, after 2 years and 11 months of construction, the total construction area 89036.79㎡ was completed, including four buildings for API, four buildings for storage warehouses, one building fro QC, one power center and one sewage treatment station. All plants are operated by gravity flow and equipped with automatic control systems such as DCS, SIS, BMS and WMS.

2022-05-31

Huapont Pharma was awarded the 2021 Outstanding Company for National Adverse Drug Reaction Monitoring and Evaluation

The National Adverse Drug Reaction Monitoring Center commended Huapont Pharm. Due to its outstanding for performing the main responsibility. Meanwhile, Huapont Pharm. is also the only pharmaceutical manufacturer in Chongqing that has been commended. Under the leadership of the Drug Safety Committee

2022-03-03

Huapont passed the NMPA GMP inspection for large-scale injection

From February 22 to February 25, 2022, and from March 1 to March 4, 2022, NMPA (National Medical Products Administration), Chongqing conducted on-site inspection for large-volume injection. The officers conducted a comprehensive inspection. including the R&D area and production site of the injection solution, specifically, the quality management and control at the site,

2021-12-29

Huapont Pharm. won the title of "Green Factory"

Huapont Pharm. was successfully approved as a municipal green factory recently by Chongqing Municipal Economic and Information Commission It is the recognition of the company's green development, healthy development and sustainable development. Huapont Pharm. Will always focus on the concept of green development, adhere to green manufacturing, vigorously promote our company's development towards low consumption, green and ecological, and strive to complete the creation of national green factories.

2021-12-17

Huapont was certified with <Certificate of Intellectual Property Management System>.

Our management system of intellectual property was inspected by Zhongbiaotong International Certification (Shenzhen) Co., Ltd. from December 8th to 10th. Huapont Management system of intellectual property was accredited as complying with the "GB/T 29490-2013 Enterprise Intellectual Property Management Specification". Huapont was certified with <Certificate of Intellectual Property Management System>.

2021-12-16

Huapont passed the NMPA GMP inspection for sterile preparation workshop

Chongqing Municipal Drug Administration conducted an inspection for sterile preparation workshop of Huapont on December 1st ~ 2nd in 2021. During inspection, quality related management documentations were comprehensively and deeply reviewed,